This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Verdecchia P et al. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983–988.
Joint National Committee on prevention detection, evaluation, and treatment of high blood pressure. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003: 289: 2560–2572.
1999 World Health Organisation—International Society Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151–183.
Pickering TG et al. How common is white coat hypertension? JAMA 1988; 259: 225–228.
Aquirre-Ramos R et al. White-coat hypertension and risk factors in recently diagnosed hypertensive patients. Gac Med Mex 2002; 138: 319–324.
Amado P et al. Arterial hypertension difficult to control in the elderly patient. The significance of the ‘white coat effect’. Rev Port Cardiol 1999; 18: 897–906.
Brown MA, Buddle ML, Martin A . Is resistant hypertension really resistant? Am J Hypertens 2001; 14: 1263–1269.
Marchesi E et al. Metabolic risk factors in white coat hypertensives. J H Hyperten 1994; 8: 475–479.
Pierdomenico SD et al. Endothelial function in sustained and white coat hypertension. Am J Hypertens 2002; 15: 946–952.
Amar J et al. Intima media thickness of the carotid artery in the white coat and ambulatory hypertension. Arch Mal Coeur Vaiss 1997; 90: 1075–1078.
Celis H et al. Cardiovascular risk in white-coat and sustained hypertensive patients. Blood Pressure 2002; 11: 325–327.
Kario K et al. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. JACC 2001; 38: 238–245.
Khattar RS, Senior R, Lahiri A . Cardiovascular outcome in white-coat versus sustained mild hypertension. Circulation 1998; 98: 1892–1897.
Hernaandez RR et al. Frequency of white coat hypertension in mild hypertension. Profile of cardiovascular risk and early organic involvement. Med Clin 1996; 106: 690–694.
Cerasola G et al. White-coat hypertension and cardiovascular risk. J Cardiovas Risk 1995; 6: 545–549.
Muscholl MW et al. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ 1998; 317: 565–570.
Muldoon MF et al. White-coat hypertension and carotid artery atherosclerosis: a matching study. Arch Intern Med 2000; 160: 1507–1512.
Mallion JM et al. Clinical value of ambulatory blood pressure monitoring. J Hyperten 1999; 17: 585–595.
Glen SK et al. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet 1996; 348: 654–657.
Stranderg TE, Salomaa V . White coat effect, blood pressure and mortality in men: prospective cohort study. Eur Heart J 2000; 21: 1714–1718.
Gustavsen PH et al. White coat hypertension is a cardiovascular risk factor. A 10-year follow-up study. J Human Hypertens, this issue.
He FJ, MacGregor GA . Cost of poor pressure control in the UK: 62000 unnecessary deaths per year. J Human Hypertens 2003; 17: 455–457
About this article
Cite this article
Chung, I., Lip, G. White coat hypertension: not so benign after all?. J Hum Hypertens 17, 807–809 (2003). https://doi.org/10.1038/sj.jhh.1001651
- white coat hypertension
This article is cited by
Current Cardiology Reports (2016)
Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function
Journal of Human Hypertension (2007)